Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 5, 2021

Primary Completion Date

July 8, 2025

Study Completion Date

July 8, 2025

Conditions
Advanced Ovarian CarcinomaStage IIIC Fallopian Tube Cancer AJCC v8Stage IIIC Ovarian Cancer AJCC v8Stage IIIC Primary Peritoneal Cancer AJCC v8Stage IV Fallopian Tube Cancer AJCC v8Stage IV Ovarian Cancer AJCC v8Stage IV Primary Peritoneal Cancer AJCC v8
Interventions
BEHAVIORAL

Behavioral Counseling

Undergo behavioral counseling

DIETARY_SUPPLEMENT

Nutritional Supplement Drink

Given Boost or Ensure

OTHER

Physical Activity

Complete physical activity assignments

OTHER

Survey Administration

Complete surveys

PROCEDURE

Computed Tomography

Undergo CT scans

PROCEDURE

Biospecimen Collection

Undergo blood collection

BEHAVIORAL

Health Education

Complete Resilient Living program

OTHER

Medical Device Usage and Evaluation

Wear a FitBit

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05047926 - Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients | Biotech Hunter | Biotech Hunter